Logo image of IVG.MI

IVECO GROUP NV (IVG.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:IVG - NL0015000LU4 - Common Stock

18.715 EUR
+0.03 (+0.16%)
Last: 12/10/2025, 7:00:00 PM
Fundamental Rating

4

IVG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 109 industry peers in the Machinery industry. While IVG is still in line with the averages on profitability rating, there are concerns on its financial health. IVG has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year IVG was profitable.
IVG had a positive operating cash flow in the past year.
Of the past 5 years IVG 4 years were profitable.
In the past 5 years IVG always reported a positive cash flow from operatings.
IVG.MI Yearly Net Income VS EBIT VS OCF VS FCFIVG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

IVG's Return On Assets of 1.73% is in line compared to the rest of the industry. IVG outperforms 40.37% of its industry peers.
IVG's Return On Equity of 12.39% is fine compared to the rest of the industry. IVG outperforms 75.23% of its industry peers.
IVG has a Return On Invested Capital (4.53%) which is in line with its industry peers.
IVG had an Average Return On Invested Capital over the past 3 years of 3.91%. This is below the industry average of 8.88%.
The 3 year average ROIC (3.91%) for IVG is below the current ROIC(4.53%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.73%
ROE 12.39%
ROIC 4.53%
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
IVG.MI Yearly ROA, ROE, ROICIVG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

IVG's Profit Margin of 2.17% is on the low side compared to the rest of the industry. IVG is outperformed by 62.39% of its industry peers.
In the last couple of years the Profit Margin of IVG has grown nicely.
Looking at the Operating Margin, with a value of 5.00%, IVG is in line with its industry, outperforming 42.20% of the companies in the same industry.
IVG's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 16.49%, IVG is not doing good in the industry: 89.91% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of IVG has grown nicely.
Industry RankSector Rank
OM 5%
PM (TTM) 2.17%
GM 16.49%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
IVG.MI Yearly Profit, Operating, Gross MarginsIVG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IVG is destroying value.
IVG has less shares outstanding than it did 1 year ago.
IVG has more shares outstanding than it did 5 years ago.
The debt/assets ratio for IVG has been reduced compared to a year ago.
IVG.MI Yearly Shares OutstandingIVG.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
IVG.MI Yearly Total Debt VS Total AssetsIVG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

IVG has an Altman-Z score of 1.77. This is a bad value and indicates that IVG is not financially healthy and even has some risk of bankruptcy.
IVG has a Altman-Z score (1.77) which is comparable to the rest of the industry.
The Debt to FCF ratio of IVG is 14.82, which is on the high side as it means it would take IVG, 14.82 years of fcf income to pay off all of its debts.
IVG has a worse Debt to FCF ratio (14.82) than 69.72% of its industry peers.
IVG has a Debt/Equity ratio of 1.35. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.35, IVG is not doing good in the industry: 81.65% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 14.82
Altman-Z 1.77
ROIC/WACC0.62
WACC7.31%
IVG.MI Yearly LT Debt VS Equity VS FCFIVG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

IVG has a Current Ratio of 1.98. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of IVG (1.98) is better than 75.23% of its industry peers.
IVG has a Quick Ratio of 1.40. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of IVG (1.40) is better than 78.90% of its industry peers.
Industry RankSector Rank
Current Ratio 1.98
Quick Ratio 1.4
IVG.MI Yearly Current Assets VS Current LiabilitesIVG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

IVG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.43%.
IVG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.82% yearly.
IVG shows a decrease in Revenue. In the last year, the revenue decreased by -7.24%.
IVG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.06% yearly.
EPS 1Y (TTM)-23.43%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-61.54%
Revenue 1Y (TTM)-7.24%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-9.61%

3.2 Future

Based on estimates for the next years, IVG will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.81% on average per year.
Based on estimates for the next years, IVG will show a small growth in Revenue. The Revenue will grow by 4.30% on average per year.
EPS Next Y-19.44%
EPS Next 2Y2.58%
EPS Next 3Y8.29%
EPS Next 5Y10.81%
Revenue Next Year-4.91%
Revenue Next 2Y1.21%
Revenue Next 3Y2.83%
Revenue Next 5Y4.3%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
IVG.MI Yearly Revenue VS EstimatesIVG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
IVG.MI Yearly EPS VS EstimatesIVG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.97, IVG is valued correctly.
Based on the Price/Earnings ratio, IVG is valued cheaply inside the industry as 83.49% of the companies are valued more expensively.
IVG's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.59.
The Price/Forward Earnings ratio is 8.55, which indicates a very decent valuation of IVG.
IVG's Price/Forward Earnings ratio is rather cheap when compared to the industry. IVG is cheaper than 90.83% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.80. IVG is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 13.97
Fwd PE 8.55
IVG.MI Price Earnings VS Forward Price EarningsIVG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IVG indicates a rather cheap valuation: IVG is cheaper than 80.73% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IVG indicates a somewhat cheap valuation: IVG is cheaper than 69.72% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.69
EV/EBITDA 5.55
IVG.MI Per share dataIVG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.43
EPS Next 2Y2.58%
EPS Next 3Y8.29%

3

5. Dividend

5.1 Amount

IVG has a Yearly Dividend Yield of 1.77%.
Compared to an average industry Dividend Yield of 2.37, IVG pays a bit more dividend than its industry peers.
Compared to the average S&P500 Dividend Yield of 2.31, IVG is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.77%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

IVG pays out 27.33% of its income as dividend. This is a sustainable payout ratio.
DP27.33%
EPS Next 2Y2.58%
EPS Next 3Y8.29%
IVG.MI Yearly Income VS Free CF VS DividendIVG.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M
IVG.MI Dividend Payout.IVG.MI Dividend Payout, showing the Payout Ratio.IVG.MI Dividend Payout.PayoutRetained Earnings

IVECO GROUP NV

BIT:IVG (12/10/2025, 7:00:00 PM)

18.715

+0.03 (+0.16%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-05 2026-02-05/amc
Inst Owners37.12%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap5.08B
Revenue(TTM)14.48B
Net Income(TTM)322.00M
Analysts72.31
Price Target20.11 (7.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.77%
Yearly Dividend0.27
Dividend Growth(5Y)N/A
DP27.33%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.8%
Min EPS beat(2)-15.44%
Max EPS beat(2)5.84%
EPS beat(4)3
Avg EPS beat(4)15.3%
Min EPS beat(4)-15.44%
Max EPS beat(4)63.53%
EPS beat(8)5
Avg EPS beat(8)15.63%
EPS beat(12)8
Avg EPS beat(12)16.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-10.1%
Max Revenue beat(2)8.56%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-10.1%
Max Revenue beat(4)9.28%
Revenue beat(8)5
Avg Revenue beat(8)0.74%
Revenue beat(12)7
Avg Revenue beat(12)2.33%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.14%
PT rev (3m)0.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.3%
EPS NY rev (1m)-7.94%
EPS NY rev (3m)-9.84%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.67%
Revenue NY rev (1m)-2.64%
Revenue NY rev (3m)-2.14%
Valuation
Industry RankSector Rank
PE 13.97
Fwd PE 8.55
P/S 0.34
P/FCF 12.69
P/OCF 3.94
P/B 1.95
P/tB 9.2
EV/EBITDA 5.55
EPS(TTM)1.34
EY7.16%
EPS(NY)2.19
Fwd EY11.69%
FCF(TTM)1.47
FCFY7.88%
OCF(TTM)4.75
OCFY25.39%
SpS54.61
BVpS9.58
TBVpS2.04
PEG (NY)N/A
PEG (5Y)0.43
Graham Number17
Profitability
Industry RankSector Rank
ROA 1.73%
ROE 12.39%
ROCE 6%
ROIC 4.53%
ROICexc 5.79%
ROICexgc 7.34%
OM 5%
PM (TTM) 2.17%
GM 16.49%
FCFM 2.7%
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
ROICexc(3y)4.85%
ROICexc(5y)N/A
ROICexgc(3y)5.77%
ROICexgc(5y)N/A
ROCE(3y)5.17%
ROCE(5y)N/A
ROICexgc growth 3Y26.65%
ROICexgc growth 5Y12.05%
ROICexc growth 3Y25.45%
ROICexc growth 5Y11.07%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
F-Score6
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 14.82
Debt/EBITDA 2.37
Cap/Depr 119.97%
Cap/Sales 6%
Interest Coverage 250
Cash Conversion 86.98%
Profit Quality 124.22%
Current Ratio 1.98
Quick Ratio 1.4
Altman-Z 1.77
F-Score6
WACC7.31%
ROIC/WACC0.62
Cap/Depr(3y)146.94%
Cap/Depr(5y)121.88%
Cap/Sales(3y)5.9%
Cap/Sales(5y)5.2%
Profit Quality(3y)212.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.43%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-61.54%
EPS Next Y-19.44%
EPS Next 2Y2.58%
EPS Next 3Y8.29%
EPS Next 5Y10.81%
Revenue 1Y (TTM)-7.24%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-9.61%
Revenue Next Year-4.91%
Revenue Next 2Y1.21%
Revenue Next 3Y2.83%
Revenue Next 5Y4.3%
EBIT growth 1Y-21.25%
EBIT growth 3Y38.23%
EBIT growth 5Y15.55%
EBIT Next Year67.57%
EBIT Next 3Y28.42%
EBIT Next 5YN/A
FCF growth 1Y-7.83%
FCF growth 3YN/A
FCF growth 5Y-8.52%
OCF growth 1Y-0.31%
OCF growth 3Y26.42%
OCF growth 5Y8.96%

IVECO GROUP NV / IVG.MI FAQ

Can you provide the ChartMill fundamental rating for IVECO GROUP NV?

ChartMill assigns a fundamental rating of 4 / 10 to IVG.MI.


Can you provide the valuation status for IVECO GROUP NV?

ChartMill assigns a valuation rating of 6 / 10 to IVECO GROUP NV (IVG.MI). This can be considered as Fairly Valued.


What is the profitability of IVG stock?

IVECO GROUP NV (IVG.MI) has a profitability rating of 5 / 10.


Can you provide the financial health for IVG stock?

The financial health rating of IVECO GROUP NV (IVG.MI) is 3 / 10.


What is the earnings growth outlook for IVECO GROUP NV?

The Earnings per Share (EPS) of IVECO GROUP NV (IVG.MI) is expected to decline by -19.44% in the next year.